Novo Nordisk plans to launch an oral version of its highly successful weight loss medication, Wegovy (semaglutide), pending approval from the United States Food and Drug...
Novo Nordisk has officially submitted a biologic marketing application for its innovative treatment, Mim8 (denecimig), to the United States Food and Drug Administration (FDA). This application...